Skip to main content

Table 1 Clinical characteristics of the studied cases

From: Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups

 

No. (%)

Age in years

 

 < 3 (infants)

8 (20%)

 3-16 (pediatric age)

27 (67.5%)

 > 16 (adults)

5 (12.5%)

Mean ± SD.

7.7 ± 6.2

Median (min.-max.)

5 (1.8-26)

Sex

 

 Male

22 (55%)

 Female

18 (45%)

Location of the mass

 

 Midline

27 (67.5%)

 Lateral

13 (32.5%)

Computerized tomography (CT) mass size

 

 < 3 cm

21 (52.5%)

 > 3 cm

19 (47.5%)

Type of surgery

 

 Gross-total resection

6 (15%)

 Near-total resection

10 (25%)

 Sub-total resection

24 (60%)

Residual size after surgery

 

 < 1.5 cm2

18 (45%)

 > 1.5 cm2

22 (55%)

Metastasis at diagnosis

 

 M0

21 (52.5%)

 M+

19 (47.5%)

Postoperative protocol

 

 No therapy

3 (7.5%)

 Radiation therapy

13 (32.5%)

 Radiation plus chemotherapy

24 (60%)

Risk stratification

 

 Standard risk

18 (45%)

 High risk

22 (55%)

Recurrence rate

 

 No

11 (27.5%)

 Yes

29 (72.5%)

Death

 

 Survival

20 (50%)

 Death

20 (50%)